Skip to main content
Clinical Trials/CTRI/2023/11/060189
CTRI/2023/11/060189
Not yet recruiting
Phase 3

A Randomised controlled trial to evaluate the effect of ormeloxifene on unscheduled vaginal bleeding in women using levonorgestrel releasing intrauterine system - NI

Dr Sushma0 sites0 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Dr Sushma

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient with abnormal uterine bleeding
  • 1\.Age group: 21 – 50 yrs
  • 2\.Endometrial biopsy showing benign
  • 3\.No distortion of endometrial cavity on USG
  • 4\.Uterine size \< 12 week
  • 5\.Willing to provide informed written

Exclusion Criteria

  • 1\.Endometrial hyperplasia with atypia /
  • Endometrial cancer
  • 2\.History of any malignancy
  • 3\.Current signs of PID
  • 4\.Endocrinopathy or other systemic disorder
  • causing heavy menstrual bleeding
  • 5\.Current signs of PID
  • 6\.Abnormal Pap smear finding
  • 7\.Pregnancy, decision of pregnancy
  • 8\.Postmenopausal

Investigators

Sponsor
Dr Sushma

Similar Trials